Treatment options for polycystic ovary syndrome

被引:183
作者
Badawy, Ahmed
Elnashar, Abubaker
机构
[1] Department of Obstetrics and Gynecology, Mansoura University, Mansoura
[2] Department of Obstetrics and Gynecology, Benha University, Benha
关键词
treatment; polycystic ovary syndrome;
D O I
10.2147/IJWH.S11304
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women. The clinical manifestation of PCOS varies from a mild menstrual disorder to severe disturbance of reproductive and metabolic functions. Management of women with PCOS depends on the symptoms. These could be ovulatory dysfunction-related infertility, menstrual disorders, or androgen-related symptoms. Weight loss improves the endocrine profile and increases the likelihood of ovulation and pregnancy. Normalization of menstrual cycles and ovulation could occur with modest weight loss as little as 5% of the initial weight. The treatment of obesity includes modifications in lifestyle (diet and exercise) and medical and surgical treatment. In PCOS, anovulation relates to low follicle-stimulating hormone concentrations and the arrest of antral follicle growth in the final stages of maturation. This can be treated with medications such as clomiphene citrate, tamoxifen, aromatase inhibitors, metformin, glucocorticoids, or gonadotropins or surgically by laparoscopic ovarian drilling. In vitro fertilization will remain the last option to achieve pregnancy when others fail. Chronic anovulation over a long period of time is also associated with an increased risk of endometrial hyperplasia and carcinoma, which should be seriously investigated and treated. There are androgenic symptoms that will vary from patient to patient, such as hirsutism, acne, and/or alopecia. These are troublesome presentations to the patients and require adequate treatment. Alternative medicine has been emerging as one of the commonly practiced medicines for different health problems, including PCOS. This review underlines the contribution to the treatment of different symptoms.
引用
收藏
页码:25 / 35
页数:11
相关论文
共 80 条
[1]
Polycystic ovarian morphology with regular ovulatory cycles: Insights into the pathophysiology of polycystic ovarian syndrome [J].
Adams, JM ;
Taylor, AE ;
Crowley, WF ;
Hall, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (09) :4343-4350
[2]
Laparoscopic treatment of polycystic ovaries: is its place diminishing? [J].
Al-Fadhli, R ;
Tulandi, T .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2004, 16 (04) :295-298
[3]
Diagnostic criteria for polycystic ovary syndrome: A reappraisal [J].
Azziz, R .
FERTILITY AND STERILITY, 2005, 83 (05) :1343-1346
[4]
Adrenal androgen excess in the polycystic ovary syndrome: Sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis [J].
Azziz, R ;
Black, V ;
Hines, GA ;
Fox, LM ;
Boots, LR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07) :2317-2323
[5]
Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial [J].
Azziz, R ;
Ehrmann, D ;
Legro, RS ;
Whitcomb, RW ;
Hanley, R ;
Fereshetian, AG ;
O'Keefe, M ;
Ghazzi, MN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1626-1632
[6]
Azziz R., 2006, UPTODATE
[7]
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selma F. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (11) :4237-4245
[8]
RETRACTED: Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial (Retracted Article) [J].
Badawy, Ahmed ;
Aal, Ibrahim Abdel ;
Abulatta, Mohamed .
FERTILITY AND STERILITY, 2009, 92 (03) :849-852
[9]
Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility [J].
Badawy, Ahmed ;
Shokeir, Tarek ;
Allam, Abdel Fattah ;
Abdelhady, Hesham .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2009, 88 (02) :187-191
[10]
Polycystic ovary syndrome and cancer [J].
Balen, A .
HUMAN REPRODUCTION UPDATE, 2001, 7 (06) :522-525